|
|
| |
|
|
| |
1
INTRODUCTION
1.1
Definitions
1.2 General diagram of the process
1.3
Terminology
1.4 Functional restrictions
2
COMPONENTS OF THE DOSSIER
2.1 Administrative data
2.2 Profile
2.3 Medicinal record
2.4 Monitoring risk factors
3 PHARMACEUTICAL ANALYSIS
3.1 Call for the medicine
3.2 Alert from the medicine database
3.3 Nature of the problem
3.4 Therapeutic intent of the prescribing physician
3.5 Pharmaceutical argument(s)
3.6 Proposal of the dispensing pharmacist
4 DECISION
4.1
Formulation
4.2 References
4.3 Applications of the decision
5 STATUS OF THE PHARMACEUTICAL OPINION
5.1 Interruption of the process
5.2 Resuming a Pharmaceutical Opinion
5.3 Validating a Pharmaceutical Opinion
6 RECORDING A PHARMACEUTICAL OPINION
6.1 Payment number
6.2 Recording a Pharmaceutical Opinion
6.3 Cancelling a Pharmaceutical Opinion
7 EDITING A PHARMACEUTICAL OPINION
7.1 Prior to editing
7.2 Required items
7.3 Structure of the Pharmaceutical Opinion
8 COMMUNICATION OF A PHARMACEUTICAL OPINION
8.1 Internal consultation
8.2 External communication
9 PHARMACOTHERAPEUTIC FOLLOW-UP DOSSIER (PTFD)
9.1 Description of a pharmacotherapeutic follow-up dossier
9.2 Application: monitoring risk factors in non-insulin-dependent diabetes
10 DATA EXTRACTION
10.1 Administrative data
10.2 Patient profile data
10.3 Data on medicines purchased
10.4 Data on the pharmaceutical analysis
10.5 Data on the decision and applications
10.6 Data on communication of the Pharmaceutical Opinion
10.7 Specific data of veterinary pharmacy
11 GENERAL REFERENCES
11.1 Concerning the Pharmaceutical Opinion and the pharmacotherapeutic follow-up dossier
11.2 Concerning the monitoring of non-insulin-dependent diabetes
11.3 Concerning dosage monitoring that depends on special factors
Download
the complete technical specifications
summary |
|
|
 |
| |
|
Pharmaceutical
Opinion and information systems
